Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    F-star Therapeutics Inc.

    NASDAQ: FSTX · Real-Time Price · USD
    7.12
    0.00 (0.00%)
    At close: Mar 08, 2023, 10:00 PM

    F-star Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 21.18M 20.8M 20.8M 21.17M 3.83M 12.28M 12.82M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 21.18M 20.8M 20.8M 21.17M 3.83M 12.28M 12.82M
    Operating Income
    		 -36.9M -32.79M -31.55M -31.14M -44.3M -38.08M -27.93M
    Interest Income
    		 n/a n/a n/a n/a n/a 8K 52K
    Pretax Income
    		 -45.31M -37.69M -34.27M -31.94M -44.84M -37.37M -28.23M
    Net Income
    		 -44.99M -37.32M -33.84M -31.57M -44.86M -37.52M -28.33M
    Selling & General & Admin
    		 23.28M 23.36M 22.4M 23.13M 23.88M 25.9M 22.63M
    Research & Development
    		 34.65M 30.09M 29.8M 29.03M 24.25M 24.46M 18.11M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 57.93M 53.45M 52.2M 52.16M 48.13M 50.36M 40.75M
    Interest Expense
    		 176K -202K -536K -844K n/a n/a -35K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 57.93M 53.45M 52.2M 52.16M 48.13M 50.36M 40.75M
    Income Tax Expense
    		 -317K -377K -422K -372K 18K 142K 95K
    Shares Outstanding (Basic)
    		 21.86M 21.57M 21.08M 20.62M 20.62M 17.02M 9.1M
    Shares Outstanding (Diluted)
    		 21.86M 21.57M 21.08M 20.62M 20.62M 17.02M 9.1M
    EPS (Basic)
    		 -2.08 -1.76 -1.79 -2.29 -3.46 -3.32 -3.11
    EPS (Diluted)
    		 -2.08 -1.76 -1.79 -2.29 -3.46 -3.32 -3.11
    EBITDA
    		 -44.12M -36.18M -33.22M -31.3M -43.33M -36.27M -27.13M
    EBIT
    		 -45.27M -27.24M -8.58M 3.19M n/a n/a -6M
    Depreciation & Amortization
    		 -7.22M -2.2M 152K 642K 1.51M 1.11M 1.11M

    Add to Watchlist